Clinical Trial Update: Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of paclitaxel and gemcitabine in stage II/III breast cancer, sponsored by the National Cancer Center in Kore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Taxol (paclitaxel)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED